Ads
related to: Stage 4 Carcinoma Cancer and Cancer Patients- Request Representative
Fill Out A Brief Form To Request
Assistance From A Representative.
- Order Brochures Here
Download An Instructional Brochure
On Ordering IMFINZI For Patients.
- Recommended Dosing
Determine The Appropriate Dosing
For A Patient On IMFINZI.
- Clinical Study Results
View Clinical Study Results
& Efficacy Info For IMFINZI.
- Nurse Website
Discover Resources For
Nurses About IMFINZI.
- Physician Resources
Find Programs & Support Resources
To Share With Your IMFINZI Patients
- Request Representative
Search results
Compugen (NASDAQ:CGEN) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 22 hours agoStockNews.com upgraded shares of Compugen (NASDAQ:CGEN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning. Separately, Truist Financial ...
ALX Oncology Holdings Inc. (NASDAQ:ALXO) CFO Peter S. Garcia Acquires 12,000 Shares
ETF DAILY NEWS· 4 days agoALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) CFO Peter S. Garcia acquired 12,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The stock was purchased at ...
Chicago Partners Investment Group LLC Grows Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 2 days agoChicago Partners Investment Group LLC raised its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 15.0% during the 4th quarter, HoldingsChannel.com reports. The fund ...
Omega Fund Management LLC Invests $10.44 Million in enGene Holdings Inc. (NASDAQ:ENGN)
ETF DAILY NEWS· 6 days agoOmega Fund Management LLC acquired a new position in shares of enGene Holdings Inc. (NASDAQ:ENGN – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 1,131,175 ...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is Perceptive Advisors LLC’s 10th Largest Position
ETF DAILY NEWS· 5 days agoPerceptive Advisors LLC lifted its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.1% during the 4th quarter, HoldingsChannel reports. The institutional ...
Raymond James Begins Coverage on Omega Therapeutics (NASDAQ:OMGA)
ETF DAILY NEWS· 3 days agoEquities research analysts at Raymond James assumed coverage on shares of Omega Therapeutics (NASDAQ:OMGA – Get Free Report) in a report released on Tuesday, Briefing.com reports. The brokerage ...
Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $23.00 at JMP Securities
ETF DAILY NEWS· 18 hours agoIovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price lowered by research analysts at JMP Securities from $25.00 to $23.00 in a note issued to investors on Thursday, Benzinga ...
Ad
related to: Stage 4 Carcinoma Cancer and Cancer Patients
